Why AKBA? Akebia Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
AKBA
$1.40+0.02 (+1.45%)
Market ClosedLast close May 1
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.